Chemotherapy: Gemcitabine remains the standard of care for pancreatic cancer

Jordan Berlin, Al B Benson III

Research output: Contribution to journalShort survey

25 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)135-137
Number of pages3
JournalNature Reviews Clinical Oncology
Volume7
Issue number3
DOIs
StatePublished - Mar 1 2010

Fingerprint

gemcitabine
Antineoplastic Antimetabolites
Deoxycytidine
Standard of Care
Pancreatic Neoplasms
Drug Therapy

ASJC Scopus subject areas

  • Oncology

Cite this

@article{ea53725db2294aea9f54183f01c1ffe3,
title = "Chemotherapy: Gemcitabine remains the standard of care for pancreatic cancer",
author = "Jordan Berlin and {Benson III}, {Al B}",
year = "2010",
month = "3",
day = "1",
doi = "10.1038/nrclinonc.2010.16",
language = "English (US)",
volume = "7",
pages = "135--137",
journal = "Nature Reviews Clinical Oncology",
issn = "1759-4774",
publisher = "Nature Publishing Group",
number = "3",

}

Chemotherapy : Gemcitabine remains the standard of care for pancreatic cancer. / Berlin, Jordan; Benson III, Al B.

In: Nature Reviews Clinical Oncology, Vol. 7, No. 3, 01.03.2010, p. 135-137.

Research output: Contribution to journalShort survey

TY - JOUR

T1 - Chemotherapy

T2 - Gemcitabine remains the standard of care for pancreatic cancer

AU - Berlin, Jordan

AU - Benson III, Al B

PY - 2010/3/1

Y1 - 2010/3/1

UR - http://www.scopus.com/inward/record.url?scp=77749277610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77749277610&partnerID=8YFLogxK

U2 - 10.1038/nrclinonc.2010.16

DO - 10.1038/nrclinonc.2010.16

M3 - Short survey

C2 - 20190797

AN - SCOPUS:77749277610

VL - 7

SP - 135

EP - 137

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

SN - 1759-4774

IS - 3

ER -